TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6476072

Group type: EXPERIMENTAL
Intervention: Southern California Postrotary Nystagmus Test (SCPNT) under bright and dim conditions
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Southern California Postrotary Nystagmus Test (SCPNT) under dark condition
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Electronystagmography (ENG) measures under all three lighting conditions
Number of subjects: 18
Study: 30842083

Group type: EXPERIMENTAL
Intervention: Ibrutinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ofatumumab
Number of subjects: 0
Study: 27918718

Group type: EXPERIMENTAL
Intervention: Onartuzumab plus Bevacizumab (Ona + Bev)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo plus Bevacizumab (Pla + Bev)
Number of subjects: 129
Study: 25872027

Group type: EXPERIMENTAL
Intervention: Laparoscopic liver resection
Number of subjects: 200
Study: 23689708

Group type: EXPERIMENTAL
Intervention: Zinc sulfate (ZnSO4) 125 mg daily for 14 days
Number of subjects: 16
Study: 21838569

Group type: EXPERIMENTAL
Intervention: Parenting‐skills training plus intensive diet and activity education (P + DA)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Parenting‐skills training alone (P)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Wait‐listed control (WLC)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 111
Study: 19470793

Group type: EXPERIMENTAL
Intervention: Legume-enriched, low glycemic index, high fermentable fiber diet (1.5 cups of cooked dry beans)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control diet (isocaloric average American diet)
Number of subjects: 23
Study: 17924360

Group type: EXPERIMENTAL
Intervention: Ignoring centres
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Incorporating centres as random effects
Number of subjects: 200

Group type: COMPARATOR
Intervention: Including centres as fixed effects
Number of subjects: 200
Study: 15285602

Group type: EXPERIMENTAL
Intervention: Pragmatically enriched contexts for 8-year-old children
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Logical responses to infelicitous 'some' statements among adults
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Working memory capacity among adults
Number of subjects: 2
Study: 10893655

Group type: EXPERIMENTAL
Intervention: Soluble aspirin
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Solid paracetamol
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Salicylic acid
Number of subjects: 16
Study: 8973072

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitor (SSRI) treatment
Number of subjects: 47

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 47

Group type: COMPARATOR
Intervention: Tourette's syndrome patients
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Responders to SSRI
Number of subjects: 47
Study: 1333637

Group type: EXPERIMENTAL
Intervention: heparin 5000 IU and dihydroergotamine 0.5 mg 8 h‐1
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Fragmin (Kabi‐Pharmacia, Sweden) 2500 IU 12 h‐1 on the day of surgery and 5000 IU 24 h‐1 throughout the observation period
Number of subjects: 18

Group type: COMPARATOR
Intervention: dextran 500 ml 12 h‐1 on the day of surgery and 500 ml on days 1, 3, and 5 postoperatively
Number of subjects: 18
Study: 6368776

Group type: EXPERIMENTAL
Intervention: Intermittent lipid infusion (8 hours/day)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Continuous lipid infusion (24 hours/day)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 28
Study: 30997492

Group type: EXPERIMENTAL
Intervention: High dairy diet (HDD: 5-6 dairy portions)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Low dairy diet (LDD: ≤1 dairy portion)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both diets (HDD and LDD)
Number of subjects: 45
Study: 28742409

Group type: EXPERIMENTAL
Intervention: 1000 IU vitamin D3 plus 1000 mg evening primrose oil (EPO)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 27450743

Group type: EXPERIMENTAL
Intervention: Smoking reduction intervention
Number of subjects: 235

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 235
Study: 24952576

Group type: EXPERIMENTAL
Intervention: Concentrated Triglyceride (rTG) fish oil: EPA of 650 mg, DHA of 450 mg
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Ethyl Ester (EE) fish oil: EPA of 756 mg, DHA of 228 mg
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Triglyceride (TG) salmon oil: EPA of 180 mg, DHA of 220 mg
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Phospholipid (PL) krill oil: EPA of 150 mg, DHA of 90 mg
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Concentrated Triglyceride (rTG) fish oil
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Krill oil and (unconcentrated) triglyceride oil
Number of subjects: 35
Study: 21701796

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adalimumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Infliximab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20686429

Group type: EXPERIMENTAL
Intervention: Paclitaxel/Carboplatin + Bevacizumab (PCB)
Number of subjects: 878

Group type: COMPARATOR
Intervention: Paclitaxel/Carboplatin (PC)
Number of subjects: 878

Group type: EXPERIMENTAL
Intervention: Paclitaxel/Carboplatin + Bevacizumab (PCB) for adenocarcinoma
Number of subjects: 878

Group type: COMPARATOR
Intervention: Paclitaxel/Carboplatin (PC) for adenocarcinoma
Number of subjects: 878
Study: 18984244

Group type: EXPERIMENTAL
Intervention: Collaborative testing (experimental group)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Individual testing (control group)
Number of subjects: 153
Study: 16158737

Group type: EXPERIMENTAL
Intervention: Combined treatment including complex physical factors (CAP‐ELM‐01)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 42
Study: 14703267

Group type: EXPERIMENTAL
Intervention: Alternative treatment models for homeless individuals with severe mental illness; details on dosage and duration not available.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Needs assessment studies; details on intervention not available.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modified ESID approach; details on intervention not available.
Number of subjects: 0
Study: 10788729

Group type: EXPERIMENTAL
Intervention: SSHIP-I participants
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: SSHIP-II participants
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: SSHIP-I women
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Changes in physical activity
Number of subjects: 371
Study: 8884297

Group type: EXPERIMENTAL
Intervention: Single Stapling Technique (SST)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Double Stapling Technique (DST)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 103
Study: 1948658

Group type: EXPERIMENTAL
Intervention: 30 mg/kg intravenous methylprednisolone before ECMO
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (no steroids)
Number of subjects: 21
Study: 30053788

Group type: EXPERIMENTAL
Intervention: Systematic functional assessment within 48 hours of admission
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Immediate rehabilitation initiated within five days after discharge
Number of subjects: 336

Group type: COMPARATOR
Intervention: Usual assessment
Number of subjects: 336

Group type: COMPARATOR
Intervention: Usual rehabilitation
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Systematic functional assessment and immediate rehabilitation
Number of subjects: 336
Study: 30918434

Group type: EXPERIMENTAL
Intervention: Khubchandani's procedure with stapled posterior rectal wall resection (group A)
Number of subjects: 93

Group type: COMPARATOR
Intervention: STARR procedure (group B)
Number of subjects: 93
Study: 28742515

Group type: EXPERIMENTAL
Intervention: Exercise program with a trained physiotherapist
Number of subjects: 145

Group type: COMPARATOR
Intervention: Paracetamol as adjunct analgesia
Number of subjects: 145
Study: 25846577

Group type: EXPERIMENTAL
Intervention: Add-on TZD
Number of subjects: 310

Group type: COMPARATOR
Intervention: Add-on glimepiride
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Add-on exenatide twice daily
Number of subjects: 310
Study: 23666976

Group type: EXPERIMENTAL
Intervention: High carbohydrate (75%) and low protein (3%) diet
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High carbohydrate and normal protein (20%) diet
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High fat (46%) and low protein diet
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High fat (60%) and normal protein diet
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Balanced diet (50% carbohydrates, 20% protein)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sleeping EE during overfeeding diets containing 20% protein
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Normal protein overfeeding
Number of subjects: 20
Study: 21864718

Group type: EXPERIMENTAL
Intervention: Culturally appropriate, group-based behavioral and social support intervention including 16 weekly group sessions and 8 weeks of telephone maintenance counseling.
Number of subjects: 155

Group type: COMPARATOR
Intervention: Minimal intervention control group receiving 16 weekly health education mailings.
Number of subjects: 155
Study: 20386476

Group type: EXPERIMENTAL
Intervention: Electrostimulation (EMS) training program applied on quadriceps muscles over 5 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no EMS training)
Number of subjects: 20
Study: 17555707

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral group program for spouses of stroke patients (15 bi-monthly 1.5 hour sessions)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Informational support (control group)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 38
Study: 15776275

Group type: EXPERIMENTAL
Intervention: Carbamazepine 200 mg/day for 6 days
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 11919661

Group type: EXPERIMENTAL
Intervention: Buprenorphine 2 mg daily
Number of subjects: 14

Group type: COMPARATOR
Intervention: Buprenorphine 4 mg/placebo on alternating days
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Buprenorphine 16 mg daily
Number of subjects: 14

Group type: COMPARATOR
Intervention: Buprenorphine 32 mg/placebo on alternating days
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: High-dose buprenorphine (regardless of schedule)
Number of subjects: 14
Study: 10227757

Group type: COMPARATOR
Intervention: Intravenous immunoglobulin (IVIG)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Plasma exchange (PE)
Number of subjects: 15
Study: 9764864

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 104

Group type: COMPARATOR
Intervention: Hydralazine
Number of subjects: 104
Study: 2526341

Group type: EXPERIMENTAL
Intervention: Penbutolol
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 835509

Group type: EXPERIMENTAL
Intervention: Iron-fortified grain products daily for 6 to 8 months
Number of subjects: 221

Group type: COMPARATOR
Intervention: Same foods without added iron (Control)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Daily ferrous sulfate administration for those with hemoglobin levels below 13 g/dl
Number of subjects: 221
Study: 31280965

Group type: EXPERIMENTAL
Intervention: 2-cm excision margin
Number of subjects: 936

Group type: COMPARATOR
Intervention: 4-cm excision margin
Number of subjects: 936
Study: 27622611

Group type: EXPERIMENTAL
Intervention: Desmopressin 0.2 mg
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 24643757

Group type: EXPERIMENTAL
Intervention: Family Communication intervention (Comunicación Familiar), delivered in six sessions lasting 2 hours each after school.
Number of subjects: 0
Study: 23317054

Group type: EXPERIMENTAL
Intervention: Liquid meal (LM)
Number of subjects: 19
Study: 22195390

Group type: EXPERIMENTAL
Intervention: 48‐h sleep‐deprived
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control
Number of subjects: 35
Study: 19103729

Group type: EXPERIMENTAL
Intervention: rAd-p53 combined with RT
Number of subjects: 82

Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 82
Study: 17016589

Group type: EXPERIMENTAL
Intervention: GSTM1 null genotype
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: GSTM1 null genotype and smoking interaction
Number of subjects: 367
Study: 12720233

Group type: EXPERIMENTAL
Intervention: 15 mm Crossflex stent (n = 112)
Number of subjects: 223

Group type: COMPARATOR
Intervention: 16 mm NIR stent (n = 111)
Number of subjects: 223
Study: 11035447

Group type: EXPERIMENTAL
Intervention: Cultural activity for a two-month period
Number of subjects: 19

Group type: COMPARATOR
Intervention: No cultural activity (control group)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Cultural activity
Number of subjects: 19

Group type: COMPARATOR
Intervention: Non-culturally stimulated group (control)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 19
Study: 9377917

Group type: EXPERIMENTAL
Intervention: In-line heat moisture exchanging filter (HMEF)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Heated wire humidifier (H-wH)
Number of subjects: 280
Study: 8408137

Group type: EXPERIMENTAL
Intervention: Arthroscopy and division of all plicae
Number of subjects: 30

Group type: COMPARATOR
Intervention: Diagnostic arthroscopy alone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Subsequent division of plicae after another arthroscopic operation
Number of subjects: 30
Study: 2430506

Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccine combined with oral penicillin-V (twice daily)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccine combined with benzathine penicillin (intramuscularly every 4 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 40
Study: 30237467

Group type: EXPERIMENTAL
Intervention: Conventional laser PRP
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Pattern scan laser (PASCAL) PRP
Number of subjects: 39

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 39
Study: 26584450

Group type: EXPERIMENTAL
Intervention: 0.3 mg ranibizumab
Number of subjects: 1098

Group type: EXPERIMENTAL
Intervention: 0.5 mg ranibizumab
Number of subjects: 1098

Group type: EXPERIMENTAL
Intervention: Laser plus 0.5 mg ranibizumab
Number of subjects: 1098

Group type: COMPARATOR
Intervention: 0.5 mg ranibizumab + laser
Number of subjects: 1098

Group type: COMPARATOR
Intervention: Laser
Number of subjects: 1098

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 1098
Study: 24745701

Group type: EXPERIMENTAL
Intervention: Grass pollen sublingual immunotherapy
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 23444750

Group type: EXPERIMENTAL
Intervention: Oral supplementation with antioxidant agents containing alpha lipoic acid (ALA) plus calcium and vitamin D3 (n = 25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Only calcium and vitamin D3 (n = 25)
Number of subjects: 50
Study: 20375919

Group type: EXPERIMENTAL
Intervention: Drains (group I, 20 patients)
Number of subjects: 39

Group type: COMPARATOR
Intervention: No drains (group II, 19 patients)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both groups (group I and group II)
Number of subjects: 39
Study: 17943615

Group type: EXPERIMENTAL
Intervention: Multidisciplinary group-based intervention programme
Number of subjects: 54

Group type: COMPARATOR
Intervention: Waitlist-control
Number of subjects: 54
Study: 16218969

Group type: EXPERIMENTAL
Intervention: Intra-oral injection of ketorolac (30 mg in 1 mL)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normal saline (1 mL)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both groups (test and control)
Number of subjects: 10
Study: 11872034

Group type: EXPERIMENTAL
Intervention: Apomorphine SL (2 mg for 2 weeks, then 3 mg for 2 weeks, and finally 4 mg for the remaining 4 weeks)
Number of subjects: 507

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Apomorphine SL
Number of subjects: 507
Study: 9989366

Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg od)
Number of subjects: 20
Study: 7787438

Group type: EXPERIMENTAL
Intervention: Adjunctive antithyroid drugs (ATD) in a form of block‐replacement regimen of methimazole (MMI) plus L‐T4 for 6 months
Number of subjects: 159

Group type: COMPARATOR
Intervention: Radioiodine (RAI) therapy alone
Number of subjects: 159
Study: 2370643

Group type: EXPERIMENTAL
Intervention: Dilevalol (acute and chronic treatment)
Number of subjects: 18
Study: 6966329

Group type: EXPERIMENTAL
Intervention: Real stimulation
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 8
Study: 31991296

Group type: EXPERIMENTAL
Intervention: Curcumin supplementation (1500 mg, three times per day) for 3 months
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 29906580

Group type: EXPERIMENTAL
Intervention: Dynamic hybrid instrumentation (Dynesys‐Transition‐Optima)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Posterior lumbar interbody fusion (PLIF)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups (PLIF and Dynesys)
Number of subjects: 30
Study: 27096854

Group type: EXPERIMENTAL
Intervention: Moringa oleifera leaves extract (200mg/kg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 20
Study: 24720268

Group type: EXPERIMENTAL
Intervention: Volatile anaesthesia
Number of subjects: 154

Group type: COMPARATOR
Intervention: Total intravenous anaesthesia
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 154
Study: 22975864

Group type: EXPERIMENTAL
Intervention: Active rTMS applied over the right dorsolateral prefrontal cortex
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 10

Group type: COMPARATOR
Intervention: Active rTMS applied over the left dorsolateral prefrontal cortex
Number of subjects: 10
Study: 19923361

Group type: EXPERIMENTAL
Intervention: Endurance training (3 months)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (no training, n = 5)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Treadmill running training (5 weeks in mice)
Number of subjects: 12
Study: 17081532

Group type: EXPERIMENTAL
Intervention: Postoperative triptorelin treatment
Number of subjects: 100
Study: 16251373

Group type: EXPERIMENTAL
Intervention: Physical exercise (weekly exercise class consisting of light aerobic exercise, muscle strengthening and stretching for 6 months)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control (ordinary activity)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 129

Group type: COMPARATOR
Intervention: Physical exercise and Control
Number of subjects: 129
Study: 12126173

Group type: EXPERIMENTAL
Intervention: Static magnets
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 10341016

Group type: EXPERIMENTAL
Intervention: ALN 10 mg/day
Number of subjects: 246
Study: 8734558

Group type: EXPERIMENTAL
Intervention: Imagery focused on increasing neutrophil adherence
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Imagery focused on decreasing neutrophil adherence
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (resting sessions without imagery training)
Number of subjects: 15
Study: 1918559

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral therapy (CT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Behavioral marital therapy (BMT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined treatment (CO)
Number of subjects: 60
Study: 6621852

Group type: EXPERIMENTAL
Intervention: Scopolamine (various doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methscopolamine
Number of subjects: 0
Study: 31447237

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced-guided liver biopsy (CEUSLB)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Ultrasound-guided liver biopsy (USLB)
Number of subjects: 144
Study: 30087294

Group type: EXPERIMENTAL
Intervention: Peppermint essential oil (100 µl)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Peppermint essential oil (50 µl and 100 µl)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 26584339

Group type: EXPERIMENTAL
Intervention: Intensive treatment (n=605)
Number of subjects: 1184

Group type: COMPARATOR
Intervention: Conventional treatment (n=579)
Number of subjects: 1184

Group type: EXPERIMENTAL
Intervention: Intensive treatment
Number of subjects: 1184

Group type: EXPERIMENTAL
Intervention: Visual acuity worse than 20/100
Number of subjects: 1184
Study: 25800041

Group type: EXPERIMENTAL
Intervention: Adjuvant intra-arterial chemotherapy (IAC) and concomitant radiotherapy (RT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Surgery alone (Control)
Number of subjects: 120
Study: 22492368

Group type: EXPERIMENTAL
Intervention: 500 mL red orange juice/d
Number of subjects: 19

Group type: COMPARATOR
Intervention: 500 mL placebo/d
Number of subjects: 19
Study: 20646715

Group type: EXPERIMENTAL
Intervention: Nebulized 5% saline
Number of subjects: 165

Group type: COMPARATOR
Intervention: Nebulized 0.9% saline (normal saline)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Nebulized 3% saline
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 165
Study: 19227904

Group type: EXPERIMENTAL
Intervention: teraflex for 3 months
Number of subjects: 80
Study: 15943578

Group type: EXPERIMENTAL
Intervention: Balanced meal (50% carbohydrates, 30% fat, 20% protein)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: High-protein meal (45% carbohydrates, 20% fat, 35% protein)
Number of subjects: 11

Group type: COMPARATOR
Intervention: High-fat meal (45% carbohydrates, 45% fat, 10% protein)
Number of subjects: 11
Study: 11815408

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 10037082

Group type: EXPERIMENTAL
Intervention: T4 (8 microg/kg birth weight per day)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200